Zobrazeno 1 - 10
of 300
pro vyhledávání: '"P. Hopmeier"'
Publikováno v:
Clinical Infection in Practice, Vol 7, Iss , Pp 100038- (2020)
Background: Tuberculosis (TB) is the leading world-wide cause of death caused by a single infectious agent. The global treatment success rate for multi-drug resistant (MDR) TB, defined as resistance to at least rifampicin and isoniazid, is estimated
Externí odkaz:
https://doaj.org/article/1b244d1eea7e49d38c3813253790c71d
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 106:41-44
Endothelial cell activations and/or dysregulations of the coagulation system are crucial parameters for the prognosis of disease in patients with IDDM. Recent data suggest that expression of the adhesion molecules E-selectin and P-selectin are marker
Publikováno v:
European Journal of Clinical Investigation. 34:205-209
Background Cardiovascular disease is associated with platelet dysfunction in patients with diabetes. Hyperglycaemia is known as an independent risk factor for micro- and macrovascular complications, and improvement of metabolic control has shown bene
Autor:
P. Hopmeier, A. Festa, N. Shnawa, G. Schernthaner, W. Krugluger, G. Boltz-Nitulescu, J. Bucher
Publikováno v:
Journal of Inherited Metabolic Disease. 23:705-712
The sulphonylurea receptor-1 (SUR-1) regulates glucose-induced insulin secretion by controlling K+-ATP channel activity of the pancreatic beta-cell membrane. In this study, we investigated the putative role of a T/G-polymorphism (exon 33, codon 1369;
Publikováno v:
Thrombosis Research. 98:571-575
lower limb and in the left iliac vein. Recurrent thromboembolism was due to a homozygous G1691A mutation in the factor V gene, leading
Publikováno v:
Diabetic Medicine. 16:656-662
Summary Aims There is increasing evidence suggesting that leptin plays a major role in the regulation of energy homeostasis, as well as in the neuroendocrine and reproductive systems. Leptin is synthesized in the human placenta. The aim of this study
Autor:
Vijay V. Kakkar, Krishna Pada Sarker, Masanori Nakata, Philippe Nguyen, Kuldip Sembhi, R.W. Stockbrügger, Accabre Rutlin, J. Finsterer, Manjari Mukherjee, Ferruccio DeLorenzo, Hitoshi Yamahata, Nancy Ranlall, O. Muftuoglu, Semra Dündar, Toshihiro Nakajima, Joop Rijken, Zbigniew Kadziola, C. Stöllberger, Yahya Buyukasik, O.I. Özcebe, Anton A. Vrij, Nilgun Sayinalp, N.Ş. İleri, S. Karaahmetoglu, Isao Kitajima, Jan W.J. van Wersch, P. Hopmeier, Marie-Geneviève Remy, Serafettin Kirazli, Takayo Arisato, Gérard Potron, Gloria Dawson, D. Özatlı, Ikuro Maruyama, A. Dossenbach-Glaninger, A. Hochfellner
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 29:310-317
A pilot study was performed to compare the thromboprophylactic effect of danaparoid, enoxaparin and dalteparin in patients with hip fracture. The study was a prospective, randomised assessor-blind, four-centre trial. Prophylaxis was given for 9–11
Publikováno v:
Hemoglobin. 22:391-395
Autor:
V. Angerer, Walter Michael Halbmayer, P. Hopmeier, W. Krugluger, Michael J. Fischer, W. Doleschel, Alexander Haushofer
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 2:145-148
Autor:
P. Hopmeier
Publikováno v:
Hämostaseologie. 13:152-156
ZusammenfassungMangelzustände an Antithrombin III, Protein C und Protein S sind vielfach mit einem erhöhten Thromboembolierisiko verbunden. Klinische Manifestationen sind beim Antithrombin-Ill-Mangel vorwiegend tiefe Venenthrombosen, während beim